Cerebral Blood Flow is an Earlier Indicator of Perfusion Abnormalities than Cerebral Blood Volume in Alzheimer's Disease

DOI Web Site Web Site 被引用文献1件
  • María Lacalle-Aurioles
    Departamento de Bioingeniería e Ingeniería Aeroespacial, Universidad Carlos III de Madrid, Leganés, Madrid, Spain
  • José M Mateos-Pérez
    Instituto de Investigación Sanitaria Gregorio Marañón,Madrid, Spain
  • Juan A Guzmán-De-Villoria
    Servicio de Radiodiagnóstico. Hospital General Universitario Gregorio Marañón, Madrid, Spain
  • Javier Olazarán
    Servicio de Neurología, Hospital General Universitario Gregorio Marañón, Madrid, Spain
  • Isabel Cruz-Orduña
    Servicio de Neurología, Hospital General Universitario Gregorio Marañón, Madrid, Spain
  • Yasser Alemán-Gómez
    Instituto de Investigación Sanitaria Gregorio Marañón,Madrid, Spain
  • María-Elena Martino
    Instituto de Investigación Sanitaria Gregorio Marañón,Madrid, Spain
  • Manuel Desco
    Departamento de Bioingeniería e Ingeniería Aeroespacial, Universidad Carlos III de Madrid, Leganés, Madrid, Spain

抄録

<jats:p> The purpose of this study was to elucidate whether cerebral blood flow (CBF) can better characterize perfusion abnormalities in predementia stages of Alzheimer's disease (AD) than cerebral blood volume (CBV) and whether cortical atrophy is more associated with decreased CBV or with decreased CBF. We compared measurements of CBV, CBF, and mean cortical thickness obtained from magnetic resonance images in a group of healthy controls, patients with mild cognitive impairment (MCI) who converted to AD after 2 years of clinical follow-up (MCI-c), and patients with mild AD. A significant decrease in perfusion was detected in the parietal lobes of the MCI-c patients with CBF parametric maps but not with CBV maps. In the MCI-c group, a negative correlation between CBF values and cortical thickness in the right parahippocampal gyrus suggests an increase in CBF that depends on cortical atrophy in predementia stages of AD. Our study also suggests that CBF deficits appear before CBV deficits in the progression of AD, as CBV abnormalities were only detected at the AD stage, whereas CBF changes were already detected in the MCI stage. These results confirm the hypothesis that CBF is a more sensitive parameter than CBV for perfusion abnormalities in MCI-c patients. </jats:p>

収録刊行物

被引用文献 (1)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ